Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (2): 147-149.doi: 10.3736/jcim20070209
• Original Clinical Research • Previous Articles Next Articles
Sheng Liu1, Yong-qiang Hua1, Zhen-ping Sun1, Song Tan2, De-ming Lu1
CLC Number:
[1] | 上海市疾病预防控制中心. 2002年上海市市区恶性肿瘤发病率[J]. 肿瘤, 2006,26(5):496 |
Shanghai Municipal Center for Disease Control Prevention. Malignant tumor incidence in urban area of Shanghai in 2002[J]. Zhong Liu, 2006,26(5):496 | |
[2] | 陈前军, 司徒红林, 周劬志 , 等. 乳宁Ⅱ号抗乳腺癌短期复发转移的临床研究[J]. 现代中西医结合杂志, 2002,11(16):1546-1548 |
Cheng QJ, Situ HL, Zhou QZ , et al. Clinical observation on preventing short-term recidivation and metastasis of breast cancer by Runing Ⅱ[J]. Xian Dai Zhong Xi Yi Jie He Za Zhi, 2002,11(16):1546-1548 | |
[3] | 阙华发, 高尚璞, 陈红风 , 等. 乳宁Ⅱ号对人乳腺癌MDA-MB-435细胞株生长转移的影响[J]. 中国中医基础医学杂志, 2002,8(7):32-34 |
Que HF, Gao SP, Chen HF , et al. Effect of ''Runing Ⅱ'' on the tumor growth and metastasis of human breast cancer cell line MDA-MB-435 in vivo and vitro[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi, 2002,8(7):32-34 | |
[4] | 吴雪卿, 高尚璞, 牟明春 , 等. 乳宁Ⅱ号对TA2小鼠乳腺癌MA-891移植瘤中血管内皮生长因子表达的影响[J]. 中国中西医结合杂志, 2004,24(3):251-253 |
Wu XQ, Gao SP, Mu MC , et al. Effect of Runing Ⅱ on expression of vascular endothelial growth factor in transplanted tumor of mammary cancer MA-891 in TA2 mice[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2004,24(3):251-253 | |
[5] | 中国抗癌协会. 新编常见恶性肿瘤诊治规范——乳腺癌分册[M]. 北京: 北京医科大学、中国协和医科大学联合出版社,1999. 23-24 |
Chinese Anti-cancer Association . New standard guidelines for diagnosis and treatment of common malignant tumors: breast cancer volume[M]. Beijing: Union Publishing House of Beijing University of Medical Science and Peking Union Medical University,1999. 23-24 | |
[6] | 吴雪卿, 阙华发, 何春梅 . 陆德铭教授治疗乳腺癌远处转移37例[J]. 上海中医药大学学报, 2000,14(1):24-26 |
Wu XQ, Que HF, He CM . 37 cases of remote metastasis of mammary carcinoma treated by Prof. Lu De-ming[J]. Shanghai Zhong Yi Yao Da Xue Xue Bao, 2000,14(1):24-26 |
[1] | Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384. |
[2] | Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364. |
[3] | Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192. |
[4] | Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212. |
[5] | Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134. |
[6] | Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64. |
[7] | Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477. |
[8] | Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394. |
[9] | Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438. |
[10] | Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294. |
[11] | Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299. |
[12] | Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281. |
[13] | Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231. |
[14] | Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202. |
[15] | Yi Xia, Lu-shao-bo Shi, Jing-hui Chang, Hua-zhang Miao, Dong Wang. Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior. Journal of Integrative Medicine, 2021, 19(3): 219-225. |
|